A triple combination of treatments on moderate COVID-19

OBJECTIVE: A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent. METHODS: A cohort of moderate COVID-19 patients (n = 54) was admitted for hospitalization...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, ChunMiao, Li, BinBin, Zhou, YuFeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122460/
https://www.ncbi.nlm.nih.gov/pubmed/34027106
http://dx.doi.org/10.1515/med-2021-0279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122460/
https://www.ncbi.nlm.nih.gov/pubmed/34027106
http://dx.doi.org/10.1515/med-2021-0279

Ejemplares similares